Literature DB >> 29045170

High Glucose Variability in Hospitalized Patients with Type 1 Diabetes Mellitus.

Vikash Dadlani1, Shrikant U Tamhane1, Aidong Sun1, Anu Sharma1, Danae A Delivanis1, Prabin Thapa2, Ricky E Carter2, Yogish C Kudva1.   

Abstract

BACKGROUND: Glucose variability (GV) has been increasingly (or more extensively) studied in patients with type 1 diabetes (T1D) in the ambulatory setting; limited data exist on GV in hospitalized patients with T1D.
MATERIALS AND METHODS: Retrospective single center cohort study, we analyzed in-hospital glucose measurements to assess GV in 736 hospitalized patients in different units over a consecutive 5-year period of time. GV was assessed by mean blood glucose (BG), Average daily risk range (ADRR), high BG index, and low BG index. To place our findings in context, we conducted a systematic review using Cochrane collaboration methodology to critically analyze current published literature on GV in hospitalized T1D patients.
RESULTS: Overall, glycemic control was suboptimal with mean BG 183 ± 51.5 mg/dL and mean ADRR 35 with only 16% patients being categorized as low risk (ADRR <20) for hypo or hyperglycemia. Patients admitted in medical units had mean BG of 194.4 ± 42.8 mg/dL (95% CI = 101.2-346.6) and ADRR of 39.4 ± 16 (95% CI = 1.3-118.7), which were higher than the patients admitted in the surgical units (mean BG 168.1 ± 35.7 (95% CI = 74.8-301.8) and mean ADRR (28.8 ± 13.1 [95% CI = 0.3-93.1]). For the systematic review, initial search yielded 2336 studies for screening, however, none of them had data specific for T1D.
CONCLUSION: GV is high in hospitalized T1D patients admitted at our tertiary care center. Review of the literature shows paucity of data regarding GV in hospitalized patients with T1D.

Entities:  

Keywords:  Glucose variability; Hospitalization; Hyperglycemia; Hypoglycemia; Type 1 diabetes

Mesh:

Substances:

Year:  2017        PMID: 29045170      PMCID: PMC6110122          DOI: 10.1089/dia.2017.0107

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  38 in total

1.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  J Clin Epidemiol       Date:  2009-07-23       Impact factor: 6.437

2.  Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians.

Authors:  Amir Qaseem; Linda L Humphrey; Roger Chou; Vincenza Snow; Paul Shekelle
Journal:  Ann Intern Med       Date:  2011-02-15       Impact factor: 25.391

3.  Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.

Authors:  Kellee M Miller; Nicole C Foster; Roy W Beck; Richard M Bergenstal; Stephanie N DuBose; Linda A DiMeglio; David M Maahs; William V Tamborlane
Journal:  Diabetes Care       Date:  2015-06       Impact factor: 19.112

4.  Evaluation of a new measure of blood glucose variability in diabetes.

Authors:  Boris P Kovatchev; Erik Otto; Daniel Cox; Linda Gonder-Frederick; William Clarke
Journal:  Diabetes Care       Date:  2006-11       Impact factor: 19.112

5.  Effects of sensor-augmented pump therapy on glycemic variability in well-controlled type 1 diabetes in the STAR 3 study.

Authors:  John B Buse; Yogish C Kudva; Tadej Battelino; Stephen N Davis; John Shin; John B Welsh
Journal:  Diabetes Technol Ther       Date:  2012-04-23       Impact factor: 6.118

6.  Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients.

Authors:  Yaseen M Arabi; Ousama C Dabbagh; Hani M Tamim; Abdullah A Al-Shimemeri; Ziad A Memish; Samir H Haddad; Sofia J Syed; Hema R Giridhar; Asgar H Rishu; Mouhamad O Al-Daker; Salim H Kahoul; Riette J Britts; Maram H Sakkijha
Journal:  Crit Care Med       Date:  2008-12       Impact factor: 7.598

7.  Benefits and risks of tight glucose control in critically ill adults: a meta-analysis.

Authors:  Renda Soylemez Wiener; Daniel C Wiener; Robin J Larson
Journal:  JAMA       Date:  2008-08-27       Impact factor: 56.272

Review 8.  Glycemic targets in hospital and barriers to attaining them.

Authors:  David B Miller
Journal:  Can J Diabetes       Date:  2014-04       Impact factor: 4.190

Review 9.  Artificial pancreas: past, present, future.

Authors:  Claudio Cobelli; Eric Renard; Boris Kovatchev
Journal:  Diabetes       Date:  2011-11       Impact factor: 9.461

10.  Real-time continuous glucose monitoring in critically ill patients: a prospective randomized trial.

Authors:  Ulrike Holzinger; Joanna Warszawska; Reinhard Kitzberger; Marlene Wewalka; Wolfgang Miehsler; Harald Herkner; Christian Madl
Journal:  Diabetes Care       Date:  2009-12-10       Impact factor: 19.112

View more
  2 in total

Review 1.  Advances in Closed-Loop Insulin Delivery Systems in Patients with Type 1 Diabetes.

Authors:  Vikash Dadlani; Jordan E Pinsker; Eyal Dassau; Yogish C Kudva
Journal:  Curr Diab Rep       Date:  2018-08-29       Impact factor: 4.810

2.  The Effects of Dietary Nutrition Intake on Glycemic Variability in Type 1 Diabetes Mellitus Adults.

Authors:  Liyuan Zhou; Mingqun Deng; Xiao Zhai; Ruiqi Yu; Jieying Liu; Miao Yu; Yuxiu Li; Xinhua Xiao
Journal:  Diabetes Ther       Date:  2021-02-27       Impact factor: 2.945

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.